|
Video: What is a Stock Split?
|
|
Coronado Biosciences is a biopharmaceutical company focused on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. Co.'s two principal product candidates in clinical development are: CNDO-201, or Trichuris suis ova, a biologic comprising the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis, multiple sclerosis, autism, psoriasis, and type one diabetes; and CNDO-109, a biologic that activates the immune system's natural killer cells to seek and destroy cancer cells, for the treatment of acute myeloid leukemia. According to our CNDO split history records, CNDO has had 1 split. | |
|
CNDO (CNDO) has 1 split in our CNDO split history database. The split for CNDO took place on February 21, 2006. This was a 1 for 10 reverse split, meaning for each 10 shares of CNDO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as CNDO conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CNDO split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CNDO shares, starting with a $10,000 purchase of CNDO, presented on a split-history-adjusted basis factoring in the complete CNDO split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/27/2015 |
|
Start price/share: |
$1.76 |
|
End price/share: |
$3.44 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
95.45% |
|
Annualized Gain: |
95.72% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$19,545.00 |
|
Years: |
1.00 |
|
|
|
Date |
Ratio |
02/21/2006 | 1 for 10 |
|
|